Arlington Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4
Closed -$1.95K 296
2023
Q3
$1.95K Hold
4
﹤0.01% 278
2023
Q2
$1.79K Sell
4
-32
-89% -$16.1K ﹤0.01% 540
2023
Q1
$17.5K Sell
36
-21
-37% -$10.4K ﹤0.01% 365
2022
Q4
$29.2K Buy
+57
New +$30K ﹤0.01% 267
2022
Q3
Sell
-106
Closed -$50K 407
2022
Q2
$50K Buy
+106
New +$47.2K 0.02% 242
2022
Q1
Sell
-25
Closed -$12K 543
2021
Q4
$12K Buy
+25
New +$11.1K ﹤0.01% 448

Other funds holding HUM

Arlington Partners's HUM Position: Q4 2023 in Review

Arlington Partners sold out of Humana (HUM) in Q4 2023, closing a stake of 4 shares — an estimated $1.95K sold.

Arlington Partners first reported a position in HUM in Q4 2021 and held it in 6 quarters. The position peaked at $50K in Q2 2022. 1,153 funds tracked by Wall St. Rank hold HUM as of Q4 2023.

  • Arlington Partners reported no remaining Humana position as of Q4 2023 after selling out during the quarter.
  • Arlington Partners sold 4 Humana shares in Q4 2023, an estimated $1.95K.
  • Arlington Partners first reported a position in Humana in Q4 2021 and held it in 6 quarters.
  • Arlington Partners's Humana position peaked at $50K in Q2 2022.
  • 1,153 funds tracked by Wall St. Rank held Humana as of Q4 2023.

Based on Arlington Partners's 13F filing for Q4 2023, filed 24 Jan 2024.